Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY

v3.21.1
CONDENSED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY - 3 months ended Mar. 31, 2021 - USD ($)
Class A Common Stock
Class A Common Stock Not Subject to Redemption
Class B Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at the beginning at Dec. 31, 2020     $ 1,035 $ 23,965 $ (12,681) $ 12,319
Balance at the beginning (in shares) at Dec. 31, 2020     10,350,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Sale of units in initial public offering, less fair value of derivative liabilities for public warrants   $ 4,140   399,919,860 0 399,924,000
Sale of units in initial public offering, less fair value of derivative liabilities for public warrants (in shares)   41,400,000        
Offering costs       (22,759,328) 0 (22,759,328)
Excess cash received over the fair value of the private warrants       3,084,000 0 3,084,000
Shares subject to possible redemption   $ (3,708)   (370,795,282) 0 (370,798,990)
Shares subject to possible redemption (in shares)   (37,079,899)        
Net loss $ 3,000   $ 4,500,000 0 (4,461,996) (4,461,996)
Balance at the end at Mar. 31, 2021   $ 432 $ 1,035 $ 9,473,215 $ (4,474,677) $ 5,000,005
Balance at the end (in shares) at Mar. 31, 2021   4,320,101 10,350,000